Simeonova M, Ivanova T, Raikov Z, Konstantinov H
Scientific Research Centre for Speciality Polymers, Sofia, Bulgaria.
Acta Physiol Pharmacol Bulg. 1994;20(3-4):77-82.
The tissue distribution of polybutylcyanoacrylate nanoparticles (PBCN) with a diameter of 127 nm, loaded with 1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1- nitrosourea (spin-labelled nitrosourea, SLCNU) is described. PBCN-suspensions were intraperitoneally (i.p.) injected into Lewis lung carcinoma bearing mice. The biodistribution of PBCN in the visceral organs, blood and tumor was studied by electron spin resonance (ESR) spectroscopy. A relatively low accumulation of nanoparticles in the liver and spleen was found. The accumulation was negligible in the i.m. implanted primary tumor. SLCNU-loaded nanoparticles were mainly found in the lungs, kidneys, and heart. The highest content of the particles studied was observed in the lungs of tumor bearing experimental animals damaged by metastases. These findings suggest that PBCN offer some opportunities in the targeting of SLCNU to lung metastases.
描述了负载1-(2-氯乙基)-3-(1-氧基-2,2,6,6-四甲基哌啶基)-1-亚硝基脲(自旋标记亚硝基脲,SLCNU)的直径为127 nm的聚氰基丙烯酸丁酯纳米颗粒(PBCN)的组织分布。将PBCN悬浮液腹腔内(i.p.)注射到携带Lewis肺癌的小鼠体内。通过电子自旋共振(ESR)光谱研究了PBCN在内脏器官、血液和肿瘤中的生物分布。发现纳米颗粒在肝脏和脾脏中的积累相对较低。在肌肉内植入的原发性肿瘤中的积累可以忽略不计。负载SLCNU的纳米颗粒主要存在于肺、肾和心脏中。在受转移损伤的荷瘤实验动物的肺中观察到所研究颗粒的最高含量。这些发现表明,PBCN在将SLCNU靶向肺转移方面提供了一些机会。